Chinese EOPD Registry

Parkinson Disease Clinical Trial

Official title: The Chinese Early-onset Parkinson's Disease Registry

Status Recruiting

Clinical Trial Summary

The purpose of the Chinese Early-onst Parkinson's disease Registry (CEOPDR) is to develop a database of persons with early-onset Parkinson's disease (EOPD) in China.

Clinical Trial Description

Parkinson's disease (PD) is the second most common disorder among degenerative neurological disease. Early-onset PD (EOPD) has its unique clinical feature and genetic basis.Investigators aim to establish a database of EOPD,and characterize the clinical feature, genetic basis, environmental factors and their interactions EOPD in China.

Method:

1. Clinical feature will be measured by scales and neurological tests.Standard scales includes: Unified Parkinson's Disease Rating Scale(UPDRS), Hoehn-Yahr stages, NMSS, MMSE, PDSS(Parkinson disease sleep scales),Rapid Eye Movement Sleep Behaviour Disorder Questionnaire(RBDQ-HK),ESS(Epworth Sleepiness Scale),Rome III functional constipation scale，SCOPA-AUT (the Scale for Outcomes in PD for Autonomic Symptoms)，PFS(Parkinson Fatigue Scale)，CH-RLSq，Hyposmia rating scale(HRS)HAMILT depression scale，the 39-item Parkinson's Disease Questionnaire(PDQ-39)，Freezing of gait scale(FOG)，dyskinesia related scales, Wearing-off scale(WO)

2. Peripheral blood from patients was collected for whole exome sequencing.

3. The environmental factors are explored by questionnaires including smoking,drinking, pesticide and heavy metals. ;

Related Conditions & MeSH terms

• Parkinson Disease

• NCT number: NCT03508960
• Study type: Observational
• Source: Xiangya Hospital of Central South University
• Contact: J Guo, Ph.D.
• Phone: +8613974936815
• Email: guojifeng2003@163.com
• Status: Recruiting
• Start date: February 1, 2017
• Completion date: February 1, 2027